Equities

Halozyme Therapeutics Inc

Halozyme Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)59.50
  • Today's Change-2.81 / -4.51%
  • Shares traded1.73m
  • 1 Year change+49.61%
  • Beta1.2818
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue829660443
OPERATING EXPENSES
Cost of revenue total19213981
Selling, general and admin. expenses, total14912250
Depreciation/amortization7143--
Unusual expense(income)2.502521
Other operating expenses, total------
Total operating expense492395188
Operating income338265255
Other, net13----
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes348249249
Provision for income taxes6747(154)
Net income after taxes282202403
Minority interest------
Net income before extra. Items282202403
Total extraordinary items------
Net income282202403
Inc.avail. to common excl. extra. Items282202403
Inc.avail. to common incl. extra. Items282202403
EPS RECONCILIATION
Basic/primary weighted average shares132137141
Basic/primary eps excl. extra items2.131.482.86
Basic/primary eps incl. extra items2.131.482.86
Dilution adjustment------
Diluted weighted average shares134141147
Diluted eps excl. extra items2.101.442.74
Diluted eps incl. extra items2.101.442.74
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental19177.53
SUPPLEMENTAL INCOME
Depreciation, supplemental116.503.00
Total special items2.502521
NORMALISED INCOME
Normalized income before taxes351274269
Effect of special items on income taxes0.484.637.34
Income tax excluding impact of special items6751(147)
Normalized income after tax284222416
Normalized income avail. to common284222416
Basic normalized EPS2.151.622.96
Diluted normalized EPS2.111.582.84
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.